DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Pracinostat is an investigational drug.
There have been 10 clinical trials for Pracinostat. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2017.
The most common disease conditions in clinical trials are Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, and Leukemia, Myeloid. The leading clinical trial sponsors are MEI Pharma, Inc., Helsinn Healthcare SA, and Medical College of Wisconsin.
There are one hundred and seventy-three US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Pracinostat
|Pracinostat in Combination With Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)||Medical College of Wisconsin||Phase 1|
|A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body||Quotient Sciences||Phase 1|
|A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The Body||Helsinn Healthcare SA||Phase 1|
Top disease conditions for Pracinostat
Top clinical trial sponsors for Pracinostat
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Pracinostat||Get Started Free||Histone deacetylase inhibitors and methods for use thereof||REACTION BIOLOGY CORP. (Malvern, PA)||Get Started Free|
|Pracinostat||Get Started Free||Anti-CS1 antibodies and antibody drug conjugates||AbbVie Biotherapeutics Inc. (Redwood City, CA)||Get Started Free|
|Pracinostat||Get Started Free||Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: III||Frequency Therapeutics, Inc. (Woburn, MA)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Pracinostat||World Intellectual Property Organization (WIPO)||WO2017030892||2035-08-14||Get Started Free|
|Pracinostat||Australia||AU2015339012||2034-10-31||Get Started Free|
|Pracinostat||Brazil||BR112017008945||2034-10-31||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|